Epigenetic events shape cancer initiation and progression.
By targeting mechanisms involved in epigenetic regulation,
epigenetic therapeutics serve as effective weapons
against cancer.
While some pediatric brain cancers have known genetic causes, many do not. Three-dimensional profiling revealed new disease mechanisms and drug targets.